Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Nanoviricides, Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 1.17M | 1.11M | −54.9K (−4.7%) |
| Value | $2.45M | $2.09M | −$353.7K (−14.5%) |
New holders (2)
Institutions that held Nanoviricides, Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Group One Trading, L.P. | 1,000 | $2.00K | 0.00% |
| Clearstead Advisors, LLC | 293 | $1.00K | 0.00% |
Sold out (4)
Institutions that held Nanoviricides, Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Alaethes Wealth LLC | 2,133 | $4.00K |
| Sandy Spring Bank | 265 | $1.00K |
| FMR LLC | 3 | $0 |
| Glassman Wealth Services | 1 | $0 |